An Approach to Establish Antemortem Diagnosis of Dementia with Lewy Bodies

  • Hiroyuki Arai
  • Makoto Higuchi
  • Nobuyuki Okamura
  • Xia Sheng Hu
  • Toshifumi Matsui
  • Hidetada Sasaki
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Abstract

Dementia with Lewy bodies (DLB) is a neurodegenerative disorder that is characterized by a progressive cognitive decline and the presence of numerous Lewy bodies (LBs) in the cortical and subcortical brain regions with a variable degree of coexisting Alzheimer-type pathology. DLB is likely to be the second most frequent cause of degenerative dementia after Alzheimer’s disease (AD) in the elderly. In 1996, the consortium on dementia with Lewy bodies (CDLB) proposed clinical and pathological criteria of DLB. However, some groups indicated a relatively poor sensitivity of the CDLB criteria to accurately detect DLB. Early and reliable antemortem detection of DLB as well as distinguishing DLB from AD are critically important for several reasons. First, extrapyramidal features of DLB patients are successfully treated by L-dopa in most cases. Further, DLB patients seem more likely to respond to Cholinesterase inhibitors than AD patients. Second, it is well documented that there is a great need to pay particular attention to life-threatening neuroleptic adverse effects in DLB. Finally, DLB may have a different rate of disease progression than AD. Here, we summarize our recent studies of functional brain imaging using positron emission tomography (PET) in an attempt to establish antemortem diagnosis of DLB.

Keywords

Positron Emission Tomography Caudate Nucleus Lewy Body Dementia With Lewy Body Dementia With Lewy Body Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Higuchi M, Tashiro M, Arai H, Okamura N, Higuchi S, Higuchi S, Itoh M, Shin R-W, Trojanowski JQ, Sasaki H. Glucose hypometabolism and neuropathological correlates in brains of Dementia with Lewy bodies. Exp. Neurol. 162, 247–256, (2000).PubMedCrossRefGoogle Scholar
  2. 2.
    Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu X-S, Takeda A, Itoh M, Sasaki H. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer’s disease. Prog. Neuro-psychopharmacology Biol. Psychiat 25,447–456, (2001).CrossRefGoogle Scholar
  3. 3.
    Hu XS, Okamura N, Arai H, Higuchi M, Matsui T, Shinkawa M, Itoh M, Ido T, Sasaki H. 18F-DOPA PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 55, 1575–1576, (2000).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Hiroyuki Arai
    • 1
  • Makoto Higuchi
  • Nobuyuki Okamura
  • Xia Sheng Hu
  • Toshifumi Matsui
  • Hidetada Sasaki
  1. 1.Department of Geriatric MedicineTohoku University School of MedicineSendai, MiyagiJapan

Personalised recommendations